|
Mar 12
|
B. Riley sees two key positives in Viking manufacturing agreement
|
|
Mar 12
|
VKTX Inks Manufacturing Deal With CordenPharma for Obesity Drug Supply
|
|
Mar 11
|
Viking strikes $150m deal to secure supply of obesity drug
|
|
Mar 11
|
Viking Therapeutics Just Inked A $150 Million Manufacturing Deal. Here's Why Shares Crumbled.
|
|
Mar 11
|
Stellantis, Tesla, Viking Therapeutics: Market Minute
|
|
Mar 11
|
Viking Therapeutics closer to bringing its Ozempic competitor to market
|
|
Mar 11
|
Update: Viking Therapeutics Shares Fall After Manufacturing Deal With CordenPharma
|
|
Mar 11
|
H.C. Wainwright says Novo results support Viking obesity potential
|
|
Mar 11
|
Viking inks CordenPharma deal to boost obesity drug supply
|
|
Mar 11
|
Viking Therapeutics Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735
|
|
Mar 9
|
This Weight Loss Stock Could Skyrocket by 462%, According to Wall Street
|
|
Mar 3
|
AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.
|
|
Feb 28
|
Viking Therapeutics, Inc. (VKTX) Ascends But Remains Behind Market: Some Facts to Note
|
|
Feb 28
|
Is Viking Therapeutics, Inc. (VKTX) the Worst Performing Mid Cap Stock to Buy According to Analysts?
|
|
Feb 28
|
1 Biotech Stock to Buy in 2025, and 1 to Avoid
|
|
Feb 28
|
3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.
|
|
Feb 26
|
Viking Therapeutics, Inc. (VKTX): A Bull Case Theory
|
|
Feb 26
|
Is Viking Therapeutics a Buy Right Now?
|
|
Feb 25
|
Perrigo Gears Up to Report Q4 Earnings: Here's What to Expect
|
|
Feb 24
|
Viking Therapeutics (VKTX): Among the Oversold Biotech Stocks to Buy Now
|